Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Enterprise Value of -$559.5 million for Q1 2026, up 29.44% on a YoY basis from -$432.2 million in Q1 2025, and up 10.92% quarter-over-quarter from -$628.1 million in Q4 2025.
Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Enterprise Value for 9 years, with the latest figure at -$559.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 29.44% year-over-year to -$559.5 million; the trailing twelve-month figure through Mar 2026 stood at -$559.5 million (up 29.44% YoY), and the FY2025 full-year result was -$628.1 million, up 5.53% from the prior year.
- Enterprise Value for Q1 2026 stood at -$559.5 million, up from -$628.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$100.0 million in Q1 2022, with the low at -$961.4 million in Q2 2024.
- Historically, Enterprise Value has averaged -$543.0 million across 5 years, with a median of -$559.5 million in 2026.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 48.95% — and 2023, when it plunged 193.81%.
- Bicycle Therapeutics' Enterprise Value stood at -$339.2 million in 2022, then plunged by 55.22% to -$526.4 million in 2023, then retreated by 26.31% to -$664.9 million in 2024, then rose by 5.53% to -$628.1 million in 2025, then gained by 10.92% to -$559.5 million in 2026.
- The last three Enterprise Value figures came in at -$559.5 million (Q1 2026), -$628.1 million (Q4 2025), and -$648.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -559.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -559.50 Mn |
| Dec 31, 2025 | -628.11 Mn |
| Sep 30, 2025 | -648.30 Mn |
| Jun 30, 2025 | -721.50 Mn |
| Mar 31, 2025 | -792.97 Mn |
| Dec 31, 2024 | -664.90 Mn |
| Sep 30, 2024 | -890.86 Mn |
| Jun 30, 2024 | -961.36 Mn |
| Mar 31, 2024 | -457.00 Mn |
| Dec 31, 2023 | -526.42 Mn |
| Sep 30, 2023 | -572.09 Mn |
| Jun 30, 2023 | -340.43 Mn |
| Mar 31, 2023 | -293.82 Mn |
| Dec 31, 2022 | -339.15 Mn |
| Sep 30, 2022 | -361.47 Mn |
| Jun 30, 2022 | -372.80 Mn |
| Mar 31, 2022 | -100.00 Mn |
| Dec 31, 2021 | -438.68 Mn |
| Jun 30, 2021 | -198.74 Mn |
| Mar 31, 2021 | -195.90 Mn |